22-03-2019
Role of delay discounting in predicting change in HBA1c for individuals with prediabetes
Auteurs: Leonard H. Epstein, Rocco A. Paluch, Jeff S. Stein, Alexandra M. Mellis, Teresa Quattrin, Lucy D. Mastrandrea, Kyle A. Bree, Mark H. Greenawald, Warren K. Bickel
Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 5/2019
Log in om toegang te krijgenshare
DELEN
Deel dit onderdeel of sectie (kopieer de link)
-
Optie A:
-
Optie B:Deel de link per e-mail
Abstract
The majority of people with prediabetes transition to type 2 diabetes. Weight gain is a known predictor of increasing the risk of diabetes, but another reason may be a focus on immediate rewards and discounting of the future. Delay discounting (DD: devaluation of future consequences) is related to obesity and poor glycemic control in persons with type 2 diabetes. This study was designed to assess whether changes in DD are associated with HbA1c change beyond BMI change in individuals with prediabetes. Hierarchical regression showed changes in BMI (p = 0.008) and the $1000 DD task (p = 0.04) were associated with HbA1c change beyond demographic characteristics, with the full model accounting for 25.8% of the variance. Those with greater BMI increases and greater increases in discounting of the future showed the greatest increases in HbA1c. DD represents a novel target to prevent progression from prediabetes to type 2 diabetes.